We are pleased to report the successful conclusion of the final in-vivo tests for GEYEDANCE, conducted in Diest, Belgium.
Our developed features and technologies were thoroughly assessed by several surgeons, providing us with important critical data and confirming their effectiveness in supporting retinal procedures.
These tests underscore the potential impact of our innovations, marking a significant achievement for the project.
Thank you to all who contributed to this big milestone. We look forward to seeing how the results from GEYEDANCE can enhance surgical precision and outcomes in the future.
